Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUT017 Gel for Cutaneous Wound Healing
NCT07463365Phase 1Not yet recruiting
- Sponsor
- Antoni Ribas
- Start
- Oct 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of LUT-017 in venous leg ulcer (VLU) (3 arms), sponsored by Antoni Ribas. Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 8 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
LUT-017
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT07463365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07463365.